Jessica Fung analyst JPMORGAN

Currently out of the existing stock ratings of Jessica Fung, 5 are a HOLD (62.5%), 3 are a BUY (37.5%).

Jessica Fung

Work Performance Price Targets & Ratings Chart

Analyst Jessica Fung, currently employed at JPMORGAN, carries an average stock price target met ratio of 100% that have a potential upside of 17.57% achieved within 245 days.

Jessica Fung’s has documented 16 price targets and ratings displayed on 3 stocks. The coverage is on Basic Materials, Healthcare sectors.

Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 01-Feb-2024.

Wall Street Analyst Jessica Fung

Analyst best performing recommendations are on ALNY (ALNYLAM PHARMACEUTICALS).
The best stock recommendation documented was for PAAS (PAN AMERICAN SILVER CORP.) at 11/4/2015. The price target of $5.75 was fulfilled within 13 days with a profit of $0.83 (12.61%) receiving and performance score of 9.7.

Average potential price target upside

PAAS Pan American Silver Corp. UTHR United Therapeutics ALNY Alnylam Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$26

$5.42 (26.34%)

$23

5 months 5 days ago
(16-Jul-2024)

3/4 (75%)

$1.82 (7.53%)

43

$35

$14.42 (70.07%)

$30

5 months 11 days ago
(10-Jul-2024)

0/3 (0%)

$12.33 (54.39%)

Buy

$18

$-2.58 (-12.54%)

$19.5

11 months 3 days ago
(18-Jan-2024)

5/7 (71.43%)

$4.45 (32.84%)

89

Buy

$22

$1.42 (6.90%)

$27

11 months 3 days ago
(18-Jan-2024)

4/7 (57.14%)

$8.45 (62.36%)

151

Buy

$20

$-0.58 (-2.82%)

$22

11 months 13 days ago
(08-Jan-2024)

5/5 (100%)

$4.76 (31.23%)

320

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jessica Fung?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?